ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3106

Regulation of ASK1 Expression By microRNA-17 and Their Correlation with Rheumatoid Arthritis Pathogenesis

Nahid Akhtar and Salahuddin Ahmed, Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, WA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: MicroRNA and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis III

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Aberrant expression of microRNAs (miRs) has shown to be critical for the pathogenesis of rheumatoid arthritis (RA). Apoptosis signal regulating kinase-1 (ASK1), a member of MAP3K family upstream of p38 and JNK MAPK has recently been associated with RA pathogenesis. Here we studied the regulation of ASK1 by miR-17 in human RA synovial fibroblasts (RA-FLS) and correlated their expressions in human RA and adjuvant induced arthritis (AIA) and collagen induced arthritis (CIA) models of RA.

Methods: Bioinformatics analysis was performed to identify miRs predicted to targets ASK1 3’UTR. ASK1 and miR-17 expressions were correlated in FLS/synovial tissue (ST) from RA (n=15), osteoarthritis (OA; n=11), or non-diseased (NL; n=8) donors using Western blotting and qRT-PCR. Effect of IL-1β (10 ng/ml) or TNF-α (20 ng/ml) with or without ASK1 inhibitor (TC-ASK-10; 12.5 μM) or ASK1 siRNA was studied on the expression of phospho-p38 (p-p38), p-JNK, IL-6, and IL-8. Luciferase assay was performed using ASK1 3’UTR construct and pre-miR-17 to verify miRNA:mRNA interaction. Effect of miR-17 overexpression and inhibition on ASK1 was evaluated by transfection of RA-FLS with pre-miR-17/anti-miR-17. Findings from human FLS were validated in AIA and CIA models. Serum miR-17 levels in RA patients, AIA and in CIA models were quantified using qRT-PCR. Effect of miR-17 overexpression on matrix metalloproteinases (MMPs) was determined in the conditioned media using MMPs protein array. p<0.05 was considered significant.

Results: Bioinformatics analysis predict miR-17 binding site in the 3’UTR region of ASK1 mRNA. Expression of miR-17 was down-regulated (70%) in RA-FLS compared to NL-FLS and inversely correlated with a significant increase in ASK1 mRNA (2.3-fold) and protein. Similar inverse correlation of miR-17 and ASK1 was also observed in RA-ST compared to NL-ST. No significant correlation was observed between miR-17 and ASK1 expression in OA-FLS or OA-ST. IL-1β or TNF-α stimulation further suppressed miR-17 expression, with a concomitant increase in ASK1 mRNA (2.2-12.5 fold) and protein in RA-FLS. Co-transfection of RA-FLS with the ASK1 reporter construct and pre-miR-17 significantly suppressed the luciferase activity (34%). Overexpression of miR-17 inhibited ASK1 protein, whereas its inhibition enhanced ASK1 protein in RA-FLS. Interestingly, inhibition of ASK1 using TC-ASK-10 resulted in a marked attenuation of p-p38, p-JNK MAPK, IL-6, and IL-8 expression in RA-FLS. Knockdown of ASK1 or overexpression of miR-17 inhibited TNF-α-induced IL-6 and IL-8 production in RA-FLS. Overexpression of miR-17 also inhibited MMP-1, -3, and -13 production in IL-1β stimulated RA-FLS. miR-17 levels were significantly lower in the serum of RA patients, AIA and in CIA models compared to controls with increased in arthritis score. In AIA and CIA studies, ASK1 expression increased with the disease progression, and correlated with lower miR-17 expression and enhanced p-p38, p-JNK, IL-6, and IL-8 expression in arthritic joints.

Conclusion: This study provides evidence for the role of ASK1 in RA pathogenesis and a novel mechanism of its regulation by miR-17 in human RA-FLS and in two different models of RA.


Disclosure: N. Akhtar, None; S. Ahmed, None.

To cite this abstract in AMA style:

Akhtar N, Ahmed S. Regulation of ASK1 Expression By microRNA-17 and Their Correlation with Rheumatoid Arthritis Pathogenesis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/regulation-of-ask1-expression-by-microrna-17-and-their-correlation-with-rheumatoid-arthritis-pathogenesis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/regulation-of-ask1-expression-by-microrna-17-and-their-correlation-with-rheumatoid-arthritis-pathogenesis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology